Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Multi-Ingredient Caffeine Products Easily Top Adverse Event List, Study Finds

This article was originally published in The Tan Sheet

Executive Summary

The vast majority of adverse events that can be attributed with near certainty to a supplement involve weight-loss or energy-enhancing products, a study conducted by Christine Haller, M.D., finds

You may also be interested in...



Stronger caffeine warnings

Connecticut Attorney General Richard Blumenthal says May 1 FDA and Novartis should strengthen warning labels on caffeine product NoDoz following the death of a 19-year-old male. Blumenthal urges stronger warning labels about the severe health consequences of overdosing and caffeine toxicity, saying the current warning labels for NoDoz and other pill forms of caffeine are inadequate. He also advises increasing the minimum age for buying NoDoz from 12 to 18. A study reported in January found many multi-ingredient supplements containing caffeine were most commonly tied to supplement-related adverse events (1"The Tan Sheet" Jan. 29, 2007, p. 3)...

Stronger caffeine warnings

Connecticut Attorney General Richard Blumenthal says May 1 FDA and Novartis should strengthen warning labels on caffeine product NoDoz following the death of a 19-year-old male. Blumenthal urges stronger warning labels about the severe health consequences of overdosing and caffeine toxicity, saying the current warning labels for NoDoz and other pill forms of caffeine are inadequate. He also advises increasing the minimum age for buying NoDoz from 12 to 18. A study reported in January found many multi-ingredient supplements containing caffeine were most commonly tied to supplement-related adverse events (1"The Tan Sheet" Jan. 29, 2007, p. 3)...

Stronger caffeine warnings

Connecticut Attorney General Richard Blumenthal says May 1 FDA and Novartis should strengthen warning labels on caffeine product NoDoz following the death of a 19-year-old male. Blumenthal urges stronger warning labels about the severe health consequences of overdosing and caffeine toxicity, saying the current warning labels for NoDoz and other pill forms of caffeine are inadequate. He also advises increasing the minimum age for buying NoDoz from 12 to 18. A study reported in January found many multi-ingredient supplements containing caffeine were most commonly tied to supplement-related adverse events (1"The Tan Sheet" Jan. 29, 2007, p. 3)...

Related Content

Topics

UsernamePublicRestriction

Register

LL1129949

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel